🇺🇸 Diprospan in United States

301 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Anaphylactic Shock — 43 reports (14.29%)
  2. Pain — 38 reports (12.62%)
  3. Arthralgia — 32 reports (10.63%)
  4. Dizziness — 29 reports (9.63%)
  5. Headache — 29 reports (9.63%)
  6. Dyspnoea — 28 reports (9.3%)
  7. Pain In Extremity — 27 reports (8.97%)
  8. Blood Pressure Increased — 26 reports (8.64%)
  9. Product Use In Unapproved Indication — 25 reports (8.31%)
  10. Asthenia — 24 reports (7.97%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Diprospan approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Diprospan in United States?

Changchun GeneScience Pharmaceutical Co., Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.